What are the considerations for successful lead identification & optimization in biotherapeutic antibody discovery?
17 Jun 2024
Salon B
Lead Identification & Optimization
![What are the considerations for successful lead identification & optimization in biotherapeutic antibody discovery?](https://cdn.asp.events/CLIENT_HubXchan_638DBA0F_0C6E_8D3C_A444829FC0C4B73E/sites/HubXChange/media/libraries/partners/WuXi-Biologics.png/fit-in/1500x9999/filters:no_upscale())
- Integrated antibody discovery mindset based on biotherapeutic MOA is critical.
- How to choose lead identification and optimization platforms?
- You get what you screen for! The importance of screening assays in lead identification & optimization.
- Assessment of functionality and developability of the lead candidates in parallel at early antibody discovery stage helps select and advance PCC candidate with desired properties.
Industry Expert